Samsara BioCapital, L.P. - Insider Non-Derivative Transactions at Mineralys Therapeutics, Inc. (MLYS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 12, 2024, Samsara BioCapital, L.P.'s relationship to Mineralys Therapeutics, Inc. (MLYS) is TenPercentOwner, and currently has 5,074,916 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other MLYS insiders.
Data Source: SEC.
Samsara BioCapital, L.P. - Insider Non-Derivative Transactions of MLYS Common Stock
Samsara BioCapital, L.P. - Insider Non-Derivative Transactions at MLYS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 13, 2024 | P -- (Common Stock) | 555555 | 13.5 | 5074916 |
| Feb 15, 2023 | C -- (Common Stock) | 3581861 | 0 | 3581861 |
| Feb 15, 2023 | P -- (Common Stock) | 937500 | 16 | 4519361 |